The company's stock price declined by nearly 4% in the recent trading session, underperforming the broader market. This drop coincided with the announcement of its upcoming 2025 fourth quarter and full year earnings conference call. The broader news environment includes political discussions on healthcare policy, such as proposals to lower drug prices and insurance premiums, and legislative gridlock over Affordable Care Act subsidies, which could impact the health insurance sector's operating environment.